Literature DB >> 27407283

Social implications of rheumatic diseases.

Anna Kłak1, Filip Raciborski1, Piotr Samel-Kowalik2.   

Abstract

Social consequences of a disease constitute limitations in performing roles relating to working life as well as family and social life caused by the disease, mainly chronic. The aim of the study was to analyze the social consequences of rheumatic diseases in the aspect of disability pensions with respect to incapacity for work and quality of life. The occurrence of rheumatic diseases is related not only to increased risk of different types of organic changes, but above all disability. In Europe almost 50% of persons suffering from diseases of the musculoskeletal system who are currently unemployed were breadwinners. Nearly 60% of them received legal disability status. The loss of work ability is, among other things, the consequence of progressive disability. In Europe 40% of persons suffering from rheumatoid arthritis (RA) had to stop working due to the disease. Most of the persons diagnosed with RA were of working age. It results in the decrease in the quality of life as well as economic difficulties (decreased incomes and increased disease-related costs). In Poland the results of the analysis of the Social Insurance Institution (ZUS) of first-time disability recognition issued for the purpose of disability pensions in 2014 showed that the incapacity for work was caused by diseases relating to general health condition (65.5%). Diseases of the musculoskeletal system were the cause of partial inability to work of 21.6% of persons who received a disability pension for the first time (as many as 5,349 certificates were issued). Early diagnosis and implementation of effective treatment are the necessary conditions for a patient to sustain activity, both professional and social, which is of crucial importance to reduce the negative effects of the disease.

Entities:  

Keywords:  disability pensions; rheumatic diseases; social effects

Year:  2016        PMID: 27407283      PMCID: PMC4918047          DOI: 10.5114/reum.2016.60216

Source DB:  PubMed          Journal:  Reumatologia        ISSN: 0034-6233


Introduction

Rheumatic diseases are chronic and progressive. They cause damage to the locomotor system and lead to patient disability [1]. These diseases significantly reduce the quality of life of the patient [1, 2]. Rheumatic complaints of the locomotor system are common and affect around 30–40% of the European population [3]. Estimates indicate that in Poland up to 400 000 persons were treated at hospitals in 2014 due to both inflammatory and non-inflammatory diseases of the joints included in the International Statistical Classification of Diseases and Related Health Problems (ICD-10) from the code M00 to M99 [4]. The most frequently occurring inflammatory rheumatic diseases include rheumatoid arthritis and spondyloarthropathies. Connective tissue diseases, such as Sjögren's syndrome, systemic lupus erythematosus, scleroderma or dermatomyositis, occur less often [5-8]. Social and health outcomes of a disease are the limitations in performing roles relating to working life, family and social life. They are caused by the disease – mainly chronic. The type of limitations may be temporary or permanent. Disability as a result of the chronic process of the disease or injury is a particular type of social effects. Social implications of the disease can be analysed in the following terms: physical and biological – as limitations in performing regular life functions, professional – meaning limitations in the ability to work or complete incapacity for work, legal – acquisition of entitlement to benefits defined in relevant legal acts, e.g. disability pensions, sickness benefits [9]. In the case of rheumatic diseases, multiple organ failures, which often lead to death, are a major consequence. The inability to function on a labour market (the loss of work ability) is also a common implication [10]. In many cases patients suffering from rheumatoid arthritis (RA), ankylosing spondylitis (AS) or psoriatic arthritis have to stop working and rely on a disability pension. This situation constitutes a risk of impoverishment of these patients. According to the data of the Central Statistical Office of Poland (GUS), the risk of extreme poverty rate in the group of pensioners was 12.5% in 2014, whereas it was significantly lower in the general population and was 7.4% [11]. It is worth underlining that inflammatory rheumatic diseases also relate to children [12]. Chronic disease of a child significantly influences the life of parents, in particular the financial situation of their household. The results of the study carried out in Germany by Minden's team in a group of 369 children suffering from juvenile idiopathic arthritis (JIA) showed that the average total cost of JIA was estimated at EUR 4663 per patient per year. The highest costs were estimated for patients with seropositive polyarthritis and systemic arthritis (EUR 7876), whereas the lowest costs were estimated for patients with persistent oligo-arthritis (EUR 2904). The costs of healthcare constituted 89% of the total costs and the costs of drugs constituted nearly half of the value. A substantial part of the costs was borne by the child's family, with a mean out-of-pocket cost of 223 euros and a mean indirect cost due to time lost from work of 270 euros per year per family. The increase in costs corresponded to the increase in: disease activity and pain, duration of the disease, time between the occurrence of symptoms and first visit to the rheumatologist. The authors of the study concluded that JIA constitutes a substantial economic burden, especially if the child is treated with biopharmaceuticals that contribute to the increase in total cost of the disease [13].

Disability

There are different definitions of a disabled person. The World Health Organisation defines three terms of disability: injury (impairment), functional disability (disability) and impairment or social disability (handicap). The first term means any deficiency or abnormal anatomy of organ structure as well as a deficiency or mental or physiological disorder of the body due to a defined congenital disorder, a disease or an injury. Functional disability means any restriction or deficiency, which results from impaired ability to perform an activity in the defined manner. Impairment or social disability means a less privileged or less favourable situation of a given individual, resulting from an injury or functional disability. This type of disability limits the fulfilment of a role relating to age, sex and social and cultural factors [14]. Disabled people in general can be divided into two basic groups: legally and biologically disabled. Legal disability is confirmed by a decision establishing disability or a degree of disability, issued by an authority empowered for that purpose. Biological disability is a subjective feeling of limitations in fulfilment of basic activities for a given age, without a disability certificate. The Central Statistical Office (GUS) defines a legally disabled person as having a valid certificate of disability issued by an authority empowered for that purpose [15]. The results of the National Population and Housing Census carried out in Poland in 2011 show that the number of persons who declared limitations in ability to perform regular basic activities for a given age and/or had a valid certificate of disability was 4 697 500, which constituted 12.2% of the population. Among people with disabilities there were 2 530 400 women. The group of men with disabilities in 2011 numbered 2 167 100 persons [15]. According to GUS data in 23.4% of households there is at least one person who holds a certificate of disability issued by the Disability Assessment Board. In 2013 in Poland disability was mostly reported in households entitled to receive a disability pension (people with disabilities occurred in 61.4% of this group of households). In the group of retirees’ households this percentage was 25.4%. As many as 10.8% of respondents at the age of 16 years or more had a certificate of disability (3% severe, 5% moderate, 2.8% mild). Over 86% of people with severe disability were under constant medical or nursing supervision [16]. In the ranking of the 10 leading causes of health loss in Central Europe, musculoskeletal disorders were ranked as fifth (after lower back pain, major depression, falls and neck pain) [17]. It should be however noted that lower back pain and neck pain are also symptoms of some musculoskeletal disorders. Rheumatic diseases influence not only the ability to work, but also everyday functioning of a patient and his or her independence. The most common problems of everyday life reported by patients suffering from rheumatic diseases include getting dressed, getting up, turning the tap on, opening the cap of a bottle, getting on the bus and not having a free seat, inability to walk the stairs and open heavy doors, and inability to stand for a long period of time [18]. The problems with performing simple activities of everyday life have a significant impact on the loss of independence, hamper social relations and may even constitute a risk of poverty. The authors of the “Fit for Work” study state that in Europe almost 50% of persons suffering from a disease of the musculoskeletal system, who are currently unemployed, were breadwinners. Nearly 60% of them received legal disability status [19]. The results of a study carried out in the years 2009–2010 in Poland, which included 1000 respondents suffering from RA (average age of 60 years) who were the patients of 50 rheumatology out-patient clinics selected at random, showed that 53% of RA patients received legal disability status. Among them 35% (19% of all respondents) are considered to be severely disabled while 64% (33% of all respondents) have a moderate degree of disability [20]. As many as 41% of respondents stated that they needed to adapt their living conditions to the limitations resulting from the disease, and only 5% out of 1000 respondents stated that they had already adjusted their environment. The most frequent adaptations include appropriate bathroom equipment (6%) and purchase of a dishwasher (5%) [20]. Rheumatic diseases can cause pain and fatigue that reduce work efficiency, which many employees do not want to reveal. Inflammatory diseases of the joints can also influence work safety, e.g. when a disease or associated pain affects the concentration or movement of a worker. The authors of the “Fit for Work” report indicate that 30% of Polish employees who suffer from rheumatoid arthritis are reluctant to disclose their condition to co-workers and superiors because they fear discrimination and 22% of employees do not inform the employers about their health issues [21]. Rheumatic diseases can hamper everyday activities, which forces many patients to leave work. It is estimated that in Europe 40% of RA patients had to stop working due to the disease. It should be kept in mind that most persons were of working age when diagnosed with RA [22]. In Europe the percentage of sickness absence due to musculoskeletal disorders (MSD) constitutes nearly half of all absences due to disease or health condition [19]. In the case of patients suffering from ankylosing spondylitis the percentage of unemployed is three times higher than in the general population [22]. As indicated by the World Bank data for Poland, disability is the main reason for inactivity for men aged 45–59 and for women aged 45–54 [23]. The results of the study carried out in Poland by Tasiemski's team (2009) indicate that almost 62% of RA patients were employed before the occurrence of disease symptoms. After the diagnosis 45% of patients had to stop working. Nearly half of the RA patients in the study had to rely on disability pension and were at high risk of poverty [24]. Experts suggest that after five years from the onset of the disease only half of RA patients are working. After ten years from the onset the number of those remaining in employment decreases to 20% [21]. As many as 32% to 50% of patients stop working within 10 years from the onset of rheumatoid arthritis. At least 12.1% of all sickness absence results from rheumatic diseases. It is estimated that in the UK almost a quarter of RA patients quit work within five years from the diagnosis of the disease. This figure can increase to 40% if the effects of co-existing conditions such as depression and cardiac and respiratory complaints are taken into account [25].

Disability pensions due to musculoskeletal disorders

The Social Insurance Institution (Zakład Ubezpieczeń Społecznych – ZUS) does not publish the information on the number of pensioners based on disease entities, which makes it impossible to carry out in-depth analysis. Detailed data broken down by ICD10 codes for diseases are available only for primary decisions. In 2014 ZUS issued a total of 6069 primary decisions for disability pensions due to diseases of the musculoskeletal system and connective tissue, out of which 88.1% were partial incapacity for work, 11.4% were total incapacity for work and 0.4% were inability to lead an independent life. ZUS data show an upward trend in the number of primary decisions issued for the purpose of disability pensions due to musculoskeletal and connective tissue disorders in the years 2012–2014 (Table I). In 2014 also 33 722 renewed decisions were issued, out of which 84.6% were partial incapacity for work, 12.6% were total incapacity for work and 2.7% were inability to lead an independent life [26].
Table I

Primary decisions of ZUS physicians issued in the years 2012–2014 by gender*

ICD10 codeDisease entityYear 2012Year 2013Year 2014
TotalMenWomenTotalMenWomenTotalMenWomen
M00-M99Diseases of the musculoskeletal system and connective tissue544031022332591434242488606936162445
M05Seropositive rheumatoid arthritis344118226380116264339119219
M06Other rheumatoid arthritis113427113949901254679
M10Gout252412323029272
M32Systemic lupus erythematosus76967691554541143
M45Ankylosing spondylitis8469157363101099415

In the case of gender ZUS distinguishes the category “undefined gender” that was not taken into account in the presented table. In 2013 there were 2 primary decisions in this category classified in the group M00-M99, in 2012–2016, and in 2014–2018.

Source: Own work based on ZUS data [26].

Primary decisions of ZUS physicians issued in the years 2012–2014 by gender* In the case of gender ZUS distinguishes the category “undefined gender” that was not taken into account in the presented table. In 2013 there were 2 primary decisions in this category classified in the group M00-M99, in 2012–2016, and in 2014–2018. Source: Own work based on ZUS data [26]. According to ZUS data of 2014 the percentage of primary decisions issued for the purpose of disability pensions by medical commissions that established a degree of work incapacity due to diseases of the musculoskeletal system was 15.7% of the total primary decisions in the group of women and 12.6% in the group of men [26]. The results of analysis of ZUS data on primary decisions issued for the purpose of disability pensions in 2014 indicate that most frequently the incapacity for work was caused by diseases related to the general state of health. The diseases were as follows: neoplasms constituted 23.5% of the total decisions, diseases of the circulatory system – 20.4%, and diseases of the musculoskeletal system that were the cause of partial incapacity for work in the case of 21.6% of individuals who received disability pension for the first time. In 2014 the percentage of primary decisions issued for the purpose of disability pensions by ZUS physicians who established a degree of incapacity for work due to diseases of the musculoskeletal system was 12.6% for men and 15.6% for women [26].

Quality of life

Rheumatic diseases, both inflammatory and non-inflammatory, significantly affect the reduction of quality of life in terms of functioning within society and mood [27-29]. The results of a meta-analysis carried out by Bujkiewicz's team (2014) confirm the increase of the HAQ1 (Health Assessment Questionnaire) indicator together with the disease duration as well as DAS28 (Disease Activity Score) among patients diagnosed with rheumatoid arthritis [30]. The study showed that RA activity significantly affects the level of pain perceived by the patient. The increase of pain assessment in the DAS28 algorithm by 12.5 ±1.2 points was observed along with the progress of the disease [31]. The results of a study carried out in Poland (Prais, 2007) indicate that the quality of life of patients with rheumatoid arthritis depend on the radiological and functional stage of the disease, and its duration. Quality of life of RA patients was evaluated with the following questionnaires: Medical Outcomes Study 36 − SF-36, Health Assessment Questionnaire − HAQ and Arthritis Impact Measurement Scale − AIMS. No significant correlations were found between the duration of the disease, the age of patients and the activity of the disease. Patients whose disease lasted longer and in whom the inflammatory processes were more active assessed their quality of life as poorer. It was found that radiological and functional stage of disease significantly affected the assessment of quality of life in the examined group. No significant differences in the evaluation of quality of life between men and women were found [32]. The results of studies carried out in Spain and Australia indicate that the quality of life of women suffering from RA is often low [31, 33]. The results of Spanish studies did not show a relation between the level of education of patients and their quality of life [31]. The HAQ score of women with RA is 1.4 and that of men with RA is 0.9 [33]. Women suffering from RA more often than men need the assistance of relatives or friends (women: 65%, men: 25%). The support is needed in the following situations: domestic responsibilities (70%), shopping (41%), handling of heavy objects (20%), transport (15%), opening jars (15%), and personal hygiene (11%) [33]. It should be noted that pain and reduced mobility that hamper everyday activities occur also in the case of osteoarthritis [34]. Patients with rheumatoid arthritis are often financially dependent on other persons (family, friends). Young persons more often speak about the negative influence of the disease (RA) on their functioning within society than persons aged 65 and more. According to young people, RA negatively affects their social life and outdoor sports activities [33]. The results of Norwegian studies show that health-related quality of life (HRQoL) is significantly lower in the group of RA patients than in the general population. It affects all age groups – both women and men (with regard to the health aspect as well as social functioning, physical condition, mental health, and emotional capacities) [35]. Kanecki's team (2013), which carried out a study on the assessment of health-related quality of life (HRQoL) in a group of patients hospitalised due to RA exacerbation (n = 58, mean age of 62.5 years), presented slightly different results. A planned 2-year observation of patients in an outpatient setting (mean duration of the study was 22–23 months) was carried out. The HRQoL analysis was performed using the SF-36 questionnaire. Statistically significant reductions in HRQoL scores were observed in social functioning (p < 0.05), whereas emotional health (p < 0.05) and mental health (p < 0.05) scores were increased [36]. The study carried out in Poland by Tasiemski's team showed that only 38% of individuals with RA were satisfied with their life, with the disease having the greatest impact on professional issues and the financial situation [24]. The results of the Polish-German study carried out by Bugajska's team (2010) showed that 95% of Polish patients with RA (n = 300) felt excluded from social life, compared to 62% of German patients (n = 137) [37]. The authors of the “Fit for Work” report found that rheumatic diseases limit the possibilities of education and decrease the chances for promotion even among persons who are professionally active [21].

Summary

Rheumatic diseases, especially inflammatory diseases, should not be viewed exclusively in the framework of health implications. The development of the disease is associated not only with increased risk of organ failure, but above all with progressive disability and increasing mental problems. This translates into reduced quality of life as well as financial difficulties (decreased income and increased disease-related costs). Early diagnosis and implementation of effective treatment are the necessary conditions for a patient to sustain activity, both professional and social, which is of crucial importance to decrease negative outcomes of the disease. Staying in the labour market is also favourable from the perspective of the social aspect and the health insurance system.
  21 in total

Review 1.  Beyond disability: measuring the social and personal consequences of osteoarthritis.

Authors:  A J Carr
Journal:  Osteoarthritis Cartilage       Date:  1999-03       Impact factor: 6.576

Review 2.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

3.  Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population.

Authors:  Till Uhlig; Jon H Loge; Ivar S Kristiansen; Tore K Kvien
Journal:  J Rheumatol       Date:  2007-05-15       Impact factor: 4.666

Review 4.  Global prevalence of ankylosing spondylitis.

Authors:  Linda E Dean; Gareth T Jones; Alan G MacDonald; Christina Downham; Roger D Sturrock; Gary J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2013-12-09       Impact factor: 7.580

5.  Predictors of impaired quality of life in patients with rheumatic diseases.

Authors:  Panagiota Anyfanti; Areti Triantafyllou; Panagiotis Panagopoulos; Georgios Triantafyllou; Athina Pyrpasopoulou; Sophia Chatzimichailidou; Nikolaos Koletsos; Ioannis Botis; Spyros Aslanidis; Stella Douma
Journal:  Clin Rheumatol       Date:  2015-12-23       Impact factor: 2.980

6.  Juvenile idiopathic arthritis morbidity rate in rural and urban areas of Poland 2008-2012.

Authors:  Małgorzata Tłustochowicz; Andrzej Śliwczyński; Petre Iltchev; Melania Brzozowska; Aleksandra Sierocka; Michał Marczak; Witold Tłustochowicz
Journal:  Ann Agric Environ Med       Date:  2015       Impact factor: 1.447

7.  [The quality of life of patients who suffer from rheumatoid arthritis in reference to their physical fitness and mental state].

Authors:  Krzysztof Prajs
Journal:  Ann Acad Med Stetin       Date:  2007

8.  Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.

Authors:  Sylwia Bujkiewicz; John R Thompson; Alex J Sutton; Nicola J Cooper; Mark J Harrison; Deborah P M Symmons; Keith R Abrams
Journal:  Value Health       Date:  2014 Jan-Feb       Impact factor: 5.725

9.  Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab.

Authors:  Joachim Listing; Jörn Kekow; Bernhard Manger; Gerd-Rüdiger Burmester; Dagmar Pattloch; Angela Zink; Anja Strangfeld
Journal:  Ann Rheum Dis       Date:  2013-11-29       Impact factor: 19.103

10.  Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey.

Authors:  Jaime C Branco; Ana M Rodrigues; Nélia Gouveia; Mónica Eusébio; Sofia Ramiro; Pedro M Machado; Leonor Pereira da Costa; Ana Filipa Mourão; Inês Silva; Pedro Laires; Alexandre Sepriano; Filipe Araújo; Sónia Gonçalves; Pedro S Coelho; Viviana Tavares; Jorge Cerol; Jorge M Mendes; Loreto Carmona; Helena Canhão
Journal:  RMD Open       Date:  2016-01-19
View more
  13 in total

1.  Stability of housekeeping genes in inflamed joints of spontaneous and collagen-induced arthritis in DBA/1 mice.

Authors:  Celia María Quiñonez-Flores; Salma Marcela López-Loeza; César Pacheco-Tena; Perla María Muñoz-Morales; Samara Acosta-Jiménez; Susana Aideé González-Chávez
Journal:  Inflamm Res       Date:  2021-04-26       Impact factor: 4.575

2.  Adaptation to inflammatory rheumatic disease: Do illness representations predict patients' physical functioning over time? A complex relationship.

Authors:  Evangelos C Karademas; Georgia Dimitraki; Emmanouil Papastefanakis; Georgia Ktistaki; Argyro Repa; Irini Gergianaki; George Bertsias; Prodromos Sidiropoulos; Panagiotis Simos
Journal:  J Behav Med       Date:  2017-09-21

Review 3.  Synovial Macrophage and Fibroblast Heterogeneity in Joint Homeostasis and Inflammation.

Authors:  Katharina Knab; David Chambers; Gerhard Krönke
Journal:  Front Med (Lausanne)       Date:  2022-04-25

4.  Future Directions of Rheumatology Training According to Saudi Vision 2030: Recommendations From a Saudi Experts Meeting.

Authors:  Rania Zaini; Ali Alrehaily; Ahmed Alhazmi; Hussein Halabi; Heba Mohamed; Hani Almoallim
Journal:  Open Access Rheumatol       Date:  2020-12-24

5.  Observational Study of a Wearable Sensor and Smartphone Application Supporting Unsupervised Exercises to Assess Pain and Stiffness.

Authors:  Caroline G M Perraudin; Vittorio P Illiano; Francesc Calvo; Emer O'Hare; Seamas C Donnelly; Ronan H Mullan; Oliver Sander; Brian Caulfield; Jonas F Dorn
Journal:  Digit Biomark       Date:  2018-10-23

6.  Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model.

Authors:  Yue Teng; Zhanhai Yin; Jing Li; Kun Li; Xu Li; Yan Zhang
Journal:  Oncotarget       Date:  2017-08-03

7.  Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Authors:  Marzena Ciechomska; Krzysztof Bonek; Michal Merdas; Patryk Zarecki; Jerzy Swierkot; Piotr Gluszko; Katarzyna Bogunia-Kubik; Wlodzimierz Maslinski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-05-09       Impact factor: 4.291

8.  Factors influencing physical activity in patients with early rheumatoid arthritis: A mixed-methods study.

Authors:  Maria Qvarfordt; Maria LE Andersson; Ingrid Larsson
Journal:  SAGE Open Med       Date:  2019-09-09

Review 9.  Renegotiating dimensions of the self: A systematic review and qualitative evidence synthesis of the lived experience of self-managing rheumatoid arthritis.

Authors:  Susie Donnelly; Molly Manning; Hasheem Mannan; Anthony G Wilson; Thilo Kroll
Journal:  Health Expect       Date:  2020-09-01       Impact factor: 3.377

10.  Preliminary Phytochemical Analysis: In-Vitro Comparative Evaluation of Anti-arthritic and Anti-inflammatory Potential of Some Traditionally Used Medicinal Plants.

Authors:  Sundas Farooq; Ghazala Shaheen; Hafiz Muhammad Asif; Muhammad Rahil Aslam; Rabia Zahid; Sehrish R Rajpoot; Sana Jabbar; Farah Zafar
Journal:  Dose Response       Date:  2022-01-10       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.